Triazole and imidazole derivatives for use as TGR5 agonists in the treatment of diabetes and obesity

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8785488
APP PUB NO 20120040985A1
SERIAL NO

13148811

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention comprises TGR5 agonists of structural formula I,

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
EXELIXIS PATENT COMPANY LLC210 EAST GRAND AVENUE POST OFFICE BOX 511 SOUTH SAN FRANCISCO CA 94080-0511

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bollu, Venkataiah San Diego, US 32 329
Boren, Brant Clayton San Diego, US 24 108
Flatt, Brenton T Poway, US 22 479
Gu, Xiao-Hui Potomac, US 16 332
Haq, Nadia Waltham, US 7 134
Hudson, Sarah San Diego, US 5 27
Julien, Jackaline Dalgard Del Mar, US 2 25
Martin, Richard San Diego, US 208 2688
Mohan, Raju Encinitas, US 118 1241
Morrissey, Michael Danville, US 42 513
Pratt, Benjamin Encinitas, US 16 248
Wang, Tie-Lin San Diego, US 32 403

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 22, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00